HSAS1人皮膚成纖維細(xì)胞、H
- 公司名稱 上海富雨生物科技有限公司
- 品牌
- 型號
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2025/4/24 14:41:08
- 訪問次數(shù) 77
聯(lián)系方式:陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時(shí)請說明是化工儀器網(wǎng)上看到的信息,謝謝!
HSAS1 人皮膚成纖維細(xì)胞
Catalogue No.: C1312
Product Format: a T25 flask
Culture Properties:貼壁
Complete Growth Medium: 89%H-DMEM+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
Item | Specifications |
a T25 flask | 2X106 |
Manual | 1 copy |
increase tumor specific immunity. Maintenance therapies including Immunomodulatory drukl, proteasome inhibitors and daratumumab exhibit a significant anti myeloma response by modulating the immune system. Lenalidomide promotes an anti-tumoral immune microenvironment, while daratumumab can potentially cause NK cell fratricide. Hence understanding the effects of commonly used maintenance drukl on the immune system